Yael Barer

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Smoking Cessation

Bioinformatics Analysis

Cardiovascular Disease

Top Venues

Advances in therapy

Journal of clinical medicine

JMIR public health and surveillance

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriel Chodick, Yael Barer, Tal Blay Hagai, Ido Keidar, Gally Rosenfeld Teper, Hagit Kopel, Neville Berkman
Epidemiology and Healthcare Service Utilization among Adults with Chronic Cough. Journal of clinical medicine 13 (11) (2024)
Yael Barer, Olga Sánchez-Soliño, Gabriel Chodick, Meital Grabarnik-John, Shiran Naftelberg Blonder, Neta Li Feurestein-Ganor, Lars Bergmann, Connie H Yan, Sivan Gazit, David Arkadir
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World Study. Advances in therapy (2024)
Yael Barer, Olga Sánchez-Soliño, Gabriel Chodick, Meital Grabarnik-John, Shiran Naftelberg Blonder, Neta Li Feurestein-Ganor, Lars Bergmann, Connie H Yan, Sivan Gazit, David Arkadir
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World Study. Advances in therapy 41 (8) (2024)
Gabriel Chodick, Yael Barer, Tal Blay Hagai, Ido Keidar, Gally Rosenfeld Teper, Hagit Kopel, Neville Berkman
Epidemiology and Healthcare Service Utilization among Adults with Chronic Cough. Journal of clinical medicine 13 (11) (2024)
Yael Barer, Olga Sánchez-Soliño, Gabriel Chodick, Meital Grabarnik-John, Shiran Naftelberg Blonder, Neta Li Feurestein-Ganor, Lars Bergmann, Connie H Yan, Sivan Gazit, David Arkadir
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World Study. Advances in therapy 41 (8) (2024)
Yael Barer, Olga Sánchez-Soliño, Gabriel Chodick, Meital Grabarnik-John, Shiran Naftelberg Blonder, Neta Li Feurestein-Ganor, Lars Bergmann, Connie H Yan, Sivan Gazit, David Arkadir
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World Study. Advances in therapy 41 (8) (2024)
Yael Barer, Raanan Cohen, Meital Grabarnik-John, Xiaolan Ye, Jorge Zamudio, Tanya Gurevich, Gabriel Chodick
Progressive supranuclear palsy's economical burden: the use and costs of healthcare resources in a large health provider in Israel. Journal of neurology (2023)
Yael Barer, Tanya Gurevich, Gabriel Chodick, Nir Giladi, Ruth Gross, Raanan Cohen, Lars Bergmann, Yash J Jalundhwala, Varda Shalev, Meital Grabarnik-John, Avner Thaler
Advanced-Stage Parkinson's Disease: From Identification to Characterization Using a Nationwide Database. Movement disorders clinical practice 9 (4) (2022)
Yael Barer, Gabriel Chodick, Raanan Cohen, Meital Grabarnik-John, Xiaolan Ye, Jorge Zamudio, Tanya Gurevich
Epidemiology of Progressive Supranuclear Palsy: Real World Data from the Second Largest Health Plan in Israel. Brain sciences 12 (9) (2022)
Chen Yanover, Barak Mizrahi, Nir Kalkstein, Karni Marcus, Pinchas Akiva, Yael Barer, Varda Shalev, Gabriel Chodick
What Factors Increase the Risk of Complications in SARS-CoV-2-Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization. JMIR public health and surveillance 6 (3) (2020)
Yael Barer, Ohad Cohen, Tali Cukierman-Yaffe
Effect of glycaemic control on cardiovascular disease in individuals with type 2 diabetes with pre-existing cardiovascular disease: A systematic review and meta-analysis. Diabetes, obesity & metabolism 21 (3) (2018)